Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
medicine
archive
research
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
study
afeat
aldehyde
aldeyra therapeutics
allergic conjunctivitis
alzheimer's disease
anti-piracy campaign
antidepressant
biology
biotech
boston
boulder/denver blog main
boulder/denver top stories
brain
brain age
brain training
bristol-myers squibb
business
business sponsored company news
cancer
cancer immunotherapy
cancer vaccine
chronic kidney disease
cognitive training
detroit blog main
detroit top stories
drugs
dry eye disease
extreme
food and drug administration
forty seven
What
new
9
×
positive
9
×
drug
research
results
available
common
data
discovery
medicine
momentum
patients
public
study
tests
therapeutics
treat
type
week
abou
according
agency
aging
aldeyra
announces
anti
antidepressant
antidepressants
approach
begins
biotechs
blood
brain
budding
campaign
cancer
cause
causing
chat
chemical
Language
unset
Current search:
positive
×
new
×
@bgr.com
1 year ago
This new type of antidepressant drug was found to work in just 2 hours
@slashgear.com
3 years ago
Psilocybin study offers hope for chronic migraine sufferers
@torrentfreak.com
4 years ago
New Anti-Piracy Campaign Piles On The Scare Tactics But Who’s Scared?
@slashgear.com
4 years ago
Another blood pressure drug tests positive for cancer-causing compound
@slashgear.com
4 years ago
UDS drug tests show false-positives for these common meds
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@extremetech.com
7 years ago
Researchers find no evidence ‘brain training’ games offset aging, cognitive decline
@venturebeat.com
8 years ago
Newron Receives Positive Opinion for Orphan Medicinal Product Designation for Sarizotan to Treat Patients with Rett Syndrome from the Committee for Orphan Medicinal Products from the European Medicines Agency